IL22433A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
IL22433A
IL22433A IL2243364A IL2243364A IL22433A IL 22433 A IL22433 A IL 22433A IL 2243364 A IL2243364 A IL 2243364A IL 2243364 A IL2243364 A IL 2243364A IL 22433 A IL22433 A IL 22433A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IL2243364A
Original Assignee
Parke Davis & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis & Co filed Critical Parke Davis & Co
Publication of IL22433A publication Critical patent/IL22433A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/22Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing two or more pyridine rings directly linked together, e.g. bipyridyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
IL2243364A 1963-11-13 1964-11-12 Pharmaceutical compositions IL22433A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32327163A 1963-11-13 1963-11-13

Publications (1)

Publication Number Publication Date
IL22433A true IL22433A (en) 1968-02-26

Family

ID=23258443

Family Applications (1)

Application Number Title Priority Date Filing Date
IL2243364A IL22433A (en) 1963-11-13 1964-11-12 Pharmaceutical compositions

Country Status (5)

Country Link
BE (1) BE655636A (en)
FR (1) FR3908M (en)
GB (1) GB1073708A (en)
IL (1) IL22433A (en)
NL (1) NL6413212A (en)

Also Published As

Publication number Publication date
NL6413212A (en) 1965-05-14
BE655636A (en) 1965-03-01
FR3908M (en) 1966-02-07
GB1073708A (en) 1967-06-28

Similar Documents

Publication Publication Date Title
MY6600045A (en) Explosive compositions
CY572A (en) Novel basic ethers and pharmaceutical compositions containing the same
USD202467S (en) Pharmaceutical tablets
MY6900365A (en) Wood-treatment compositions
IL22433A (en) Pharmaceutical compositions
IE27478L (en) Pharmaceutical composition
AU287999B2 (en) Pharmaceutical compositions
AU284428B2 (en) Pharmaceutical compositions
CA672940A (en) Pharmaceutical compositions
AU278747B2 (en) Pharmaceutical compositions
AU278760B2 (en) Pharmaceutical compositions
AU281371B2 (en) New pharmaceutical compositions
AU4664864A (en) Pharmaceutical compositions
AU4969664A (en) Pharmaceutical compositions
AU4212364A (en) Pharmaceutical compositions
AU3047863A (en) Pharmaceutical compositions
IE27635L (en) Emollient compositions
AU4771064A (en) New pharmaceutical compositions
IE26299L (en) Pharmaceutical compositions
CA663640A (en) Therapeutic compositions
CA661922A (en) Therapeutic compositions
CA662816A (en) Therapeutic compositions comprising 5-nitrofurfurylidenecarbazates
CA658959A (en) Polychloroprene-asphalt compositions
CA656502A (en) Polyethylene-wax compositions
CA669979A (en) Steroid-flavonoid compositions